Tonight, several A-share companies made some big moves. Let's pick a few to discuss:

**Joy and sorrow that kind**
ST Huatong is preparing to lift the delisting warning and has applied to revoke the risk warning—finally able to take a breath. On the other hand, Leike Defense is busy acquiring the minority shareholder rights of its subsidiary Yao Yun Technology to strengthen control.

Hengrui Medicine has obtained a clinical trial approval for a new drug (SHR-4610 injection), adding another member to its research and development pipeline. New Friend Co., Ltd. has signed a memorandum of cooperation with Grundfos Pumps to make some progress in liquid cooling technology for data centers.

**Sell-off warning is here**
Three senior executives of Gaomeng New Materials are preparing to cash out slightly, totaling no more than 0.061%—this proportion is indeed small. The shareholder of Weiao Co., Ltd., Ruize Investment, is taking larger actions, planning to reduce its holdings by up to 3%. Huasheng Lithium Battery is even more ruthless, as Dongjin Industry has cumulatively reduced its holdings by 1.585 million shares over the past three months.

Old rule: Executives selling shares is not necessarily a bad thing, but the market is sensitive. Make your own judgment.